Monoclonal Antibody Plus Chemotherapy in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: trastuzumab|DRUG: paclitaxel
Sponsor: National Institutes of Health Clinical Center (CC)
Collaborators: National Cancer Institute (NCI)